Health Canada says the proposed changes to the Patented Medicines Prices Review Board could be between $8-billion and $24-billion over the next decade, but Innovative Medicines Canada's study by PCDI Market Access predicts impacts of $26-billion to $35-billion.
Health Minister Ginette Petitpas Taylor speaks to media before Question Period in October. One of the minister's mandate letter commitments is reducing Canadians' high drug costs. The Hill Times photograph by Andrew Meade
Brand name drug companies are warning the government to think through its proposed regulations for the Patented Medicines Prices Review Board, saying it could curb investment in Canadian research and development.
People. Policy. Politics. This is an exclusive subscriber-only story.
Though divisive politics has become a regular feature of political culture in Canada, thanks in part to the rhetoric from the country's southern neighbours, some MPs say there's been pushback to that kind of messaging.
A former CSIS analyst says the RCMP had a ‘strong case’ against journalist Ben Makuch, but the vice-president of the Canadian Journalists for Free Expression says the ruling will ‘hurt the institution of journalism.'
Independent Senator Kim Pate, who will be among those in attendance at Nicholas Kasirer's hearing next week, is interested in hearing about his views about how systemic inequality can affect access to justice.